IMPORTANT NOTICE | Mayberry Investments Limited is a cashless institution.

Mayberry Investments Limited is a cashless institution.
Please note that cash deposits into any Mayberry account held at commercial banks, whether made in-branch or via Automated Banking Machines (ABMs), are not accepted and will not be processed. For information on accepted payment methods, please contact your Investment Advisor.

EPLY reports 12% increase in year end net profit

April 1, 2022

Eppley Limited for the year ended December 31, 2021 reported interest income of $386.56 million a 16% or $53.65 million increase when compared to the $332.91 million recorded for the corresponding period in 2020. Total interest income for the quarter amounted to $97.96 million a 15% increase when compared to the $85.24 million recorded for the same quarter in 2020.

Interest expenses for the period amounted to $285.62 million, a 38% increase when compared to $207.68 million recorded for the prior year.

Consequently, net interest income for the financial year fell 19% to total $100.94 million down from the $125.23 million recorded in the corresponding period of 2020. Net interest income for the fourth quarter amounted to $18.68 million relative to $31.49 million in 2020.

Asset Management fee income amounted to $219.11 million (2020: $194.24 million) while fees and other operating income for the period closed at $140 million relative to the $85.98 million booked for 2020.

Administrative expenses rose 11% for the year to close at $211.69 million up from $190.16 million recorded in the previous year.

Eppley recorded a total of $21.58 million for share of net profit from joint venture accounted for using the equity method for the period relative to the $10.82 million recorded for the corresponding period in FY2020.

Net impairment losses of financial and contracts assets totalled $1.47 million versus $939,000 documented in the prior comparable year.

As such, pre-tax profit closed at $268.47 million for the year ended December 31, 2021, 19% more than the $225.17 million booked in 2020. A tax charge of $16.83 million was booked, relative to the tax credit of $168,000 reported a year prior.  This resulted in a net profit attributable to shareholders of $251.63 million, a 12% increase from the $225.34 million recorded for the same period in 2020. Net profit for the quarter amounted to $60.75 million, a 8% uptick when compared with the $56.27 million recorded for the last quarter in 2020.

Total comprehensive income for the year amounted to $266.09 million (2020: $271.28 million).

Earnings per share for the quarter amounted to $0.32 (2020: $0.29). Earnings per share for the year ended December 31, 2021 totalled $1.31 compared to $1.17 for the corresponding period in 2020. The total amount of shares outstanding used for this calculation was 192,468,300 units. Notably, the stock price for EPLY closed the trading period on March 31, 2022 at J$41.87 with a corresponding P/E ratio of 32.03 times.

Eppley noted, “Our growth in profitability continues to be led by the fees we earn managing or administering assets in our real estate, mezzanine and infrastructure strategies. These fees provide a source of recurring predictable cash flow. Our proprietary portfolio is our second source of earnings. We are starting to see a recovery in the growth of the gross income we earn from our own investments. We expect that this will translate into increases in our income net of financing costs in the short-term.”

Balance Sheet Highlights:

As at December 31, 2021, total assets amounted to $5.52 billion, relative to the $4.14 billion recorded a year ago. The increase in assets was driven primarily by increases in ‘Lease receivables’ which closed at $1.70 billion (2020: $587.13 million).

Shareholder’s Equity as at December 31, 2021 totalled $1.09 billion (2020: $1 billion) resulting in a book value per share of approximately $5.66 relative to $5.22 in 2020.

 

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_453968572
June 15, 2026   Jamaica Stock Exchange Limited (JSE) has advised that the Company is managing a cybersecurity incident that was recently id…
shutterstock_453968572
June 15, 2026   Scotia Group Jamaica Limited (SGJ) has advised of the following appointments to the Board of Directors of the Company and i…
shutterstock_453968572
June 15, 2026   Eppley Limited (EPLY) has advised that Mr. Maxim Rochester has resigned as a Director of the Company and Chairman of the Au…
shutterstock_148562033
June 15, 2026   Supreme Ventures Limited (SVL) has advised that during the period June 11 to 12, 2026, a related entity purchased a total o…
shutterstock_148562033
June 15, 2026   Dolla Financial Services Limited (DOLLA) has advised that Mayberry Holdings Limited (MHL) and Mayberry Jamaican Equities Li…
shutterstock_316932977-700x441
June 15, 2026 Guyana is expected to remain one of the strongest-performing economies in the Caribbean and wider Latin American region as expandin…
shutterstock_537598660
June 15, 2026 The Limners and Bards Limited (LAB) Unaudited financials for the six months ended April 30, 2026: The Limners and Bards Limited (LAB)…
shutterstock_537598660
June 15, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the six months ended April 30, 2026: Indies Pharma Jamaica Limi…